Page last updated: 2024-09-03

mk 0663 and Colorectal Cancer

mk 0663 has been researched along with Colorectal Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bachman, KE; Bonnette, WG; Chen, H; Connolly, PJ; Dallas, S; Diloreto, KA; Dong, Y; Edwards, JP; Evans, DC; Ghosh, A; King, P; Li, X; Liao, D; Pande, V; Patel, S; Pietrak, B; Sensenhauser, C; Shi, Y; Suarez, J; Szewczuk, L; Tian, G; Wang, J; Wilde, T; Zhang, Z1

Other Studies

1 other study(ies) available for mk 0663 and Colorectal Cancer

ArticleYear
Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer.
    Journal of medicinal chemistry, 2021, 08-12, Volume: 64, Issue:15

    Topics: Animals; Antineoplastic Agents; Celecoxib; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Etoricoxib; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Structure-Activity Relationship

2021